{
  "patient_id": "maria_r",
  "extraction_metadata": {
    "extracted_from": [
      "01_Prior_Auth_Request_Form.pdf",
      "02_Laboratory_Results.pdf",
      "03_Colonoscopy_Report.pdf",
      "04_MRI_Pelvis_Report.pdf",
      "05_Clinical_Summary.pdf"
    ],
    "extraction_date": "2026-01-25",
    "extraction_method": "clinical_document_extraction"
  },

  "demographics": {
    "first_name": "Maria",
    "last_name": "Rodriguez",
    "date_of_birth": "1988-05-22",
    "age": 36,
    "gender": "Female",
    "ethnicity": "Hispanic",
    "address": {
      "street": "2847 Maple Creek Drive",
      "city": "Dallas",
      "state": "TX",
      "zip": "75201"
    },
    "phone": "214-555-0198",
    "mrn": "MARIA_R",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "insurance": {
    "primary": {
      "payer_name": "Cigna",
      "payer_id": "CIGNA",
      "plan_name": "Cigna PPO Plus",
      "plan_type": "PPO",
      "member_id": "CIG789456123",
      "group_number": "TX-PPO-2024",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  },

  "prescriber": {
    "name": "Dr. James Wilson",
    "credentials": "MD, FACG",
    "npi": "1234567890",
    "specialty": "Gastroenterology",
    "practice_name": "Dallas Digestive Disease Associates",
    "address": {
      "street": "3500 Gaston Avenue, Suite 450",
      "city": "Dallas",
      "state": "TX",
      "zip": "75246"
    },
    "phone": "214-555-0100",
    "fax": "214-555-0101",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "medication_request": {
    "medication_name": "Infliximab",
    "brand_name": "Inflectra",
    "generic_name": "infliximab-dyyb",
    "j_code": "Q5103",
    "product_type": "preferred_biosimilar",
    "dose": "5mg/kg",
    "route": "Intravenous infusion",
    "frequency": {
      "induction": "Weeks 0, 2, 6",
      "maintenance": "Every 8 weeks"
    },
    "duration_requested": "12 months initial authorization",
    "quantity_requested": "4 infusions",
    "site_of_care": "Outpatient infusion center",
    "start_date_requested": "2026-01-15",
    "source_document": "01_Prior_Auth_Request_Form.pdf"
  },

  "diagnoses": [
    {
      "rank": "primary",
      "icd10_code": "K50.913",
      "description": "Crohn's disease, unspecified, with fistula",
      "status": "active",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "rank": "secondary",
      "icd10_code": "K60.3",
      "description": "Anal fistula",
      "status": "active",
      "source_document": "01_Prior_Auth_Request_Form.pdf",
      "coding_note": "Source document listed K60.30 which is invalid; corrected to K60.3 per ICD-10-CM"
    },
    {
      "rank": "secondary",
      "icd10_code": "D50.9",
      "description": "Iron deficiency anemia, unspecified",
      "status": "active",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  ],

  "disease_activity": {
    "assessment_date": "2024-10-18",
    "cdai_score": 425,
    "cdai_interpretation": "Severe active disease (CDAI >300)",
    "ses_cd_score": 22,
    "ses_cd_interpretation": "Severe endoscopic activity",
    "harvey_bradshaw_index": 16,
    "hbi_interpretation": "Severe disease activity (HBI >=16)",
    "disease_severity": "severe",
    "disease_phenotype": "fistulizing",
    "source_documents": ["01_Prior_Auth_Request_Form.pdf", "05_Clinical_Summary.pdf"]
  },

  "clinical_history": {
    "chief_complaint": "Worsening abdominal pain, bloody diarrhea 8-12x daily, perianal drainage, unintentional weight loss of 14 lbs in 6 weeks",
    "history_of_present_illness": "36-year-old Hispanic female with known severe Crohn's disease diagnosed February 2023, now presenting with rapidly progressive disease activity despite conventional therapy. Patient reports 8-12 loose bloody stools daily, severe cramping abdominal pain primarily in RLQ rated 7-8/10, significant fatigue rendering her unable to work, and unintentional weight loss of 14 lbs (8% body weight) over 6 weeks. Developed perianal fistula in August 2024 confirmed by MRI, with persistent purulent drainage causing significant distress and inability to sit for prolonged periods. Three ED visits in past 30 days for severe symptoms requiring IV hydration and pain management; most recent visit prompted discussion of hospitalization. Failed multiple steroid tapers with disease flare upon reduction below 20mg prednisone — currently steroid-dependent at 25mg with ongoing active disease. Azathioprine discontinued after 6 weeks due to severe intolerance (hepatotoxicity with ALT 3x ULN). Mesalamine provided inadequate response at maximum dose. Prescribing physician attests that delay in biologic initiation poses risk of bowel obstruction, abscess formation, and need for emergent surgery given fistulizing phenotype with severe luminal disease.",
    "er_visits_recent": {
      "count": 3,
      "timeframe": "30 days",
      "reason": "Severe symptoms requiring IV hydration and pain management; most recent visit included surgical consultation"
    },
    "weight_loss": {
      "amount_lbs": 14,
      "percentage_body_weight": 8,
      "timeframe_weeks": 6,
      "clinical_significance": "Clinically significant involuntary weight loss indicating severe disease activity and nutritional compromise"
    },
    "concurrent_biologic_therapy": {
      "status": "none",
      "statement": "Patient is not currently receiving any biologic, biosimilar, or targeted synthetic small molecule therapy. No concurrent biologic or JAK inhibitor use.",
      "last_reviewed": "2024-10-18",
      "source_document": "05_Clinical_Summary.pdf"
    },
    "source_document": "05_Clinical_Summary.pdf"
  },

  "prior_treatments": [
    {
      "medication_name": "Mesalamine",
      "brand_name": "Pentasa",
      "drug_class": "5-ASA",
      "dose": "1g QID (4g total daily)",
      "start_date": "2023-02-15",
      "end_date": "2023-08-01",
      "duration_weeks": 24,
      "outcome": "inadequate_response",
      "outcome_description": "Inadequate response for moderate-to-severe Crohn's disease. Patient had persistent symptoms despite 6 months at maximum FDA-approved dose.",
      "adequate_trial": true,
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "medication_name": "Prednisone",
      "drug_class": "Corticosteroid",
      "dose": "40mg initially, multiple taper attempts",
      "start_date": "2023-03-01",
      "end_date": "2024-06-15",
      "duration_weeks": 67,
      "outcome": "steroid_dependent",
      "outcome_description": "Steroid-dependent disease confirmed after 4 failed taper attempts. Disease activity returns at doses below 20mg prednisone.",
      "taper_attempts": 4,
      "adequate_trial": true,
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    },
    {
      "medication_name": "Azathioprine",
      "brand_name": "Imuran",
      "drug_class": "Thiopurine immunomodulator",
      "dose": "100mg (1.7mg/kg)",
      "start_date": "2023-08-01",
      "end_date": "2023-09-15",
      "duration_weeks": 6,
      "outcome": "intolerance",
      "outcome_description": "Severe intolerance within 6 weeks of initiation. Patient developed intractable nausea and vomiting, followed by hepatotoxicity with ALT elevated to 3x upper limit of normal.",
      "adverse_event": {
        "type": "hepatotoxicity",
        "details": "ALT 3x ULN",
        "severity": "severe"
      },
      "adequate_trial": false,
      "reason_inadequate": "discontinued_due_to_adverse_event",
      "source_document": "01_Prior_Auth_Request_Form.pdf"
    }
  ],

  "laboratory_results": {
    "collection_date": "2024-10-15",
    "accession_number": "26025-200019",
    "ordering_provider": "Dr. James Wilson",
    "facility": "Clinical Laboratory Services",
    "facility_clia": "45D0987654",
    "report_status": "FINAL",
    "source_document": "02_Laboratory_Results.pdf",

    "panels": {
      "cbc": {
        "panel_name": "Complete Blood Count (CBC)",
        "results": [
          {"test": "WBC", "value": 11.2, "unit": "x10^9/L", "reference_range": "4.5-11.0", "flag": "H"},
          {"test": "RBC", "value": 3.8, "unit": "x10^12/L", "reference_range": "4.0-5.5", "flag": "L"},
          {"test": "Hemoglobin", "value": 9.4, "unit": "g/dL", "reference_range": "12.0-16.0", "flag": "L"},
          {"test": "Hematocrit", "value": 28.8, "unit": "%", "reference_range": "36-46", "flag": "L"},
          {"test": "MCV", "value": 76, "unit": "fL", "reference_range": "80-100", "flag": "L"},
          {"test": "MCH", "value": 26.8, "unit": "pg", "reference_range": "27-33", "flag": "L"},
          {"test": "Platelets", "value": 425, "unit": "x10^9/L", "reference_range": "150-400", "flag": "H"}
        ]
      },
      "cmp": {
        "panel_name": "Comprehensive Metabolic Panel (CMP)",
        "results": [
          {"test": "Sodium", "value": 138, "unit": "mEq/L", "reference_range": "136-145", "flag": null},
          {"test": "Potassium", "value": 3.6, "unit": "mEq/L", "reference_range": "3.5-5.0", "flag": null},
          {"test": "Chloride", "value": 102, "unit": "mEq/L", "reference_range": "98-106", "flag": null},
          {"test": "CO2", "value": 24, "unit": "mEq/L", "reference_range": "23-29", "flag": null},
          {"test": "BUN", "value": 18, "unit": "mg/dL", "reference_range": "7-20", "flag": null},
          {"test": "Creatinine", "value": 0.8, "unit": "mg/dL", "reference_range": "0.6-1.2", "flag": null},
          {"test": "Glucose", "value": 92, "unit": "mg/dL", "reference_range": "70-100", "flag": null},
          {"test": "Calcium", "value": 8.8, "unit": "mg/dL", "reference_range": "8.5-10.5", "flag": null},
          {"test": "Total Protein", "value": 6.2, "unit": "g/dL", "reference_range": "6.0-8.3", "flag": null},
          {"test": "Albumin", "value": 2.6, "unit": "g/dL", "reference_range": "3.5-5.0", "flag": "L"},
          {"test": "Total Bilirubin", "value": 0.6, "unit": "mg/dL", "reference_range": "0.1-1.2", "flag": null},
          {"test": "Alkaline Phosphatase", "value": 72, "unit": "U/L", "reference_range": "44-147", "flag": null},
          {"test": "AST", "value": 24, "unit": "U/L", "reference_range": "10-40", "flag": null},
          {"test": "ALT", "value": 28, "unit": "U/L", "reference_range": "7-56", "flag": null}
        ]
      },
      "inflammatory_markers": {
        "panel_name": "Inflammatory Markers",
        "results": [
          {"test": "CRP", "value": 42, "unit": "mg/L", "reference_range": "0-5", "flag": "H"},
          {"test": "ESR", "value": 55, "unit": "mm/hr", "reference_range": "0-20", "flag": "H"}
        ]
      },
      "gi_markers": {
        "panel_name": "GI-Specific Markers",
        "results": [
          {"test": "Fecal Calprotectin", "value": 1450, "unit": "ug/g", "reference_range": "<50", "flag": "H"}
        ]
      },
      "iron_studies": {
        "panel_name": "Iron Studies",
        "results": [
          {"test": "Iron", "value": 35, "unit": "ug/dL", "reference_range": "60-170", "flag": "L"},
          {"test": "TIBC", "value": 420, "unit": "ug/dL", "reference_range": "250-370", "flag": "H"},
          {"test": "Ferritin", "value": 8, "unit": "ng/mL", "reference_range": "12-150", "flag": "L", "interpretation_note": "Below reference range; in setting of active inflammation (CRP 42), represents severe iron deficiency as ferritin is an acute phase reactant"},
          {"test": "Transferrin Saturation", "value": 8, "unit": "%", "reference_range": "20-50", "flag": "L"}
        ],
        "clinical_interpretation": "Classic iron deficiency anemia pattern: low iron, elevated TIBC, low transferrin saturation. Ferritin at lower limit despite inflammation indicates true iron deficiency."
      }
    },

    "interpretation": "Results demonstrate severely active inflammatory bowel disease with markedly elevated inflammatory markers (CRP 42, ESR 55, FCP 1450), severe iron deficiency anemia (Hgb 9.4, ferritin 8), and hypoalbuminemia (2.6) indicating significant nutritional compromise. Clinical picture consistent with severe Crohn's disease requiring urgent escalation to biologic therapy. Pre-biologic TB and Hepatitis B screening ordered — results pending."
  },

  "procedures": {
    "colonoscopy": {
      "procedure_name": "Colonoscopy with Ileoscopy and Biopsy",
      "procedure_date": "2024-09-28",
      "accession_number": "ENDO260256586",
      "facility": "Dallas Digestive Endoscopy Center",
      "performed_by": "Dr. James Wilson, MD, FACG",
      "indication": "Crohn's disease - assessment of disease activity and extent",
      "sedation": "Propofol sedation",
      "source_document": "03_Colonoscopy_Report.pdf",

      "findings": {
        "terminal_ileum": {
          "description": "Severe inflammation with deep linear and serpiginous ulcerations, cobblestoning of mucosa, luminal narrowing without obstruction",
          "severity": "severe",
          "mucosal_involvement": "70%"
        },
        "cecum": {
          "description": "Moderate inflammation with scattered aphthous ulcers and erythema",
          "severity": "moderate"
        },
        "ascending_colon": {
          "description": "Moderate to severe inflammation with skip lesions, multiple deep ulcerations, friable mucosa with contact bleeding",
          "severity": "moderate_to_severe"
        },
        "transverse_colon": {
          "description": "Mild patchy inflammation, edematous mucosa",
          "severity": "mild"
        },
        "descending_colon": {
          "description": "Normal appearing mucosa - skip pattern confirmed",
          "severity": "normal"
        },
        "sigmoid_colon": {
          "description": "Normal",
          "severity": "normal"
        },
        "rectum": {
          "description": "Mild inflammation near dentate line, perianal fistula opening visualized",
          "severity": "mild",
          "fistula_observed": true
        }
      },

      "endoscopic_score": {
        "score_type": "SES-CD",
        "score_value": 22,
        "interpretation": "severe endoscopic activity"
      },

      "biopsies": [
        {"location": "Terminal ileum", "specimens": 4},
        {"location": "Ascending colon", "specimens": 4},
        {"location": "Transverse colon", "specimens": 2}
      ],

      "pathology": {
        "report_date": "2024-10-02",
        "pathologist": "Dr. Karen Lee, MD",
        "microscopic_findings": "Active chronic colitis with crypt architectural distortion, cryptitis, and crypt abscesses. Non-caseating granulomas identified in terminal ileum specimens.",
        "granulomas_present": true,
        "granuloma_location": "terminal ileum",
        "dysplasia": "none",
        "diagnosis": "Active Crohn's disease involving terminal ileum and colon"
      },

      "impression": "Severe active Crohn's disease with deep ulcerations, fistulizing phenotype, and extensive mucosal involvement. Urgent escalation to biologic therapy recommended given disease severity, conventional therapy failure, and risk of surgical complications."
    },

    "mri_pelvis": {
      "procedure_name": "MRI Pelvis with and without contrast",
      "procedure_date": "2024-10-05",
      "accession_number": "MR2602544255",
      "facility": "Dallas Medical Center",
      "performed_by": "Dr. Michael Chen, MD - Radiology",
      "ordering_provider": "Dr. James Wilson",
      "indication": "Evaluate perianal fistula",
      "technique": "T1, T2, STIR sequences, post-gadolinium T1 fat-sat",
      "comparison": "No prior pelvic MRI available for comparison",
      "source_document": "04_MRI_Pelvis_Report.pdf",

      "findings": {
        "fistula_classification": {
          "system": "Parks Classification",
          "type": "Intersphincteric fistula"
        },
        "primary_tract": {
          "description": "Single fistula tract originating at dentate line (6 o'clock position), traversing intersphincteric plane",
          "location": "6 o'clock",
          "plane": "intersphincteric"
        },
        "external_opening": {
          "description": "Single external opening 2.5 cm from anal verge, perianal skin",
          "distance_from_anal_verge": "2.5 cm"
        },
        "secondary_tracts": "None identified",
        "abscess": {
          "present": false,
          "description": "No abscess collection identified"
        },
        "sphincter_involvement": {
          "internal_sphincter": "involved",
          "external_sphincter": "intact"
        },
        "rectal_wall": "Mild wall thickening in distal rectum"
      },

      "impression": "Simple intersphincteric perianal fistula associated with Crohn's disease. No abscess. External sphincter intact.",
      "recommendation": "Clinical correlation. Consider biologic therapy for fistulizing Crohn's disease. Surgical consultation if persistent despite medical therapy."
    }
  },

  "pre_biologic_screening": {
    "status": "ORDERED_PENDING",
    "source_document": "05_Clinical_Summary.pdf",
    "clinical_context": "Screening tests ordered at time of biologic therapy decision. Results expected within 5-7 business days. Given severe disease activity (CDAI 425, 3 ER visits in 30 days, fistulizing phenotype), prescriber has determined that the risk of delaying PA submission outweighs the risk of awaiting screening results.",

    "tuberculosis_screening": {
      "status": "ORDERED_PENDING",
      "test_ordered": "QuantiFERON-TB Gold Plus",
      "order_date": "2024-10-18",
      "expected_result_date": "2024-10-25",
      "required_tests": ["QuantiFERON-TB Gold", "T-SPOT.TB", "PPD with chest X-ray"],
      "documentation_available": false,
      "risk_assessment": "Patient has no TB risk factors (no endemic area travel, no known exposures, no immunosuppression history prior to current corticosteroid use). Low pre-test probability."
    },

    "hepatitis_b_screening": {
      "status": "ORDERED_PENDING",
      "test_ordered": "Hepatitis B Panel (HBsAg, anti-HBc, anti-HBs)",
      "order_date": "2024-10-18",
      "expected_result_date": "2024-10-25",
      "required_tests": ["HBsAg", "anti-HBc", "anti-HBs"],
      "documentation_available": false,
      "risk_assessment": "Patient received childhood HBV vaccination series per immunization records. Low risk for active or chronic HBV."
    },

    "hepatitis_c_screening": {
      "status": "ORDERED_PENDING",
      "test_ordered": "HCV Antibody",
      "order_date": "2024-10-18",
      "expected_result_date": "2024-10-25",
      "required_tests": ["HCV Antibody"],
      "documentation_available": false
    }
  },

  "documentation_gaps": [
    {
      "gap_id": "GAP-001",
      "gap_type": "pre_biologic_screening",
      "description": "Tuberculosis (TB) screening ordered but results pending at time of submission",
      "required_by_policy": true,
      "payers_requiring": ["Cigna", "UHC"],
      "impact": "EXPEDITED_FOLLOW_UP",
      "gap_status": "ordered_pending",
      "expected_resolution_date": "2024-10-25",
      "resolution_action": "Submit QuantiFERON-TB Gold result as supplemental documentation when available (expected within 5-7 business days)",
      "clinical_urgency_override": "Severe fistulizing Crohn's disease (CDAI 425, 3 ER visits/30 days) — prescriber attests delay in biologic initiation poses risk of surgical emergency",
      "source_document": "05_Clinical_Summary.pdf"
    },
    {
      "gap_id": "GAP-002",
      "gap_type": "pre_biologic_screening",
      "description": "Hepatitis B screening panel ordered but results pending at time of submission",
      "required_by_policy": true,
      "payers_requiring": ["Cigna", "UHC"],
      "impact": "EXPEDITED_FOLLOW_UP",
      "gap_status": "ordered_pending",
      "expected_resolution_date": "2024-10-25",
      "resolution_action": "Submit complete Hepatitis B panel as supplemental documentation when available (expected within 5-7 business days)",
      "clinical_urgency_override": "Patient has documented childhood HBV vaccination — low pre-test probability of active infection",
      "source_document": "05_Clinical_Summary.pdf"
    }
  ],

  "pa_criteria_assessment": {
    "diagnosis_confirmed": {
      "met": true,
      "evidence": "ICD-10 K50.913 documented on PA form; colonoscopy confirms active Crohn's disease with granulomas",
      "source_documents": ["01_Prior_Auth_Request_Form.pdf", "03_Colonoscopy_Report.pdf"]
    },
    "disease_severity_documented": {
      "met": true,
      "evidence": "CDAI 425, SES-CD 22, HBI 16 — all indicate severe active disease. CRP 42, ESR 55, FCP 1450, albumin 2.6 confirm systemic inflammation and nutritional compromise.",
      "source_documents": ["01_Prior_Auth_Request_Form.pdf", "05_Clinical_Summary.pdf", "02_Laboratory_Results.pdf"]
    },
    "conventional_therapy_failed": {
      "met": true,
      "therapies_tried": [
        {"medication": "Mesalamine", "outcome": "inadequate_response", "duration_adequate": true},
        {"medication": "Prednisone", "outcome": "steroid_dependent", "duration_adequate": true},
        {"medication": "Azathioprine", "outcome": "intolerance", "duration_adequate": false, "reason": "hepatotoxicity"}
      ],
      "source_documents": ["01_Prior_Auth_Request_Form.pdf"]
    },
    "step_therapy_satisfied": {
      "met": true,
      "evidence": "Failed 5-ASA (24 weeks), corticosteroids (67 weeks, steroid-dependent), immunomodulator (intolerance)",
      "source_documents": ["01_Prior_Auth_Request_Form.pdf"]
    },
    "pre_biologic_screening_complete": {
      "met": false,
      "status": "ordered_pending",
      "missing": ["TB screening (ordered, results pending)", "Hepatitis B panel (ordered, results pending)"],
      "expected_completion": "2024-10-25",
      "source_documents": ["02_Laboratory_Results.pdf", "05_Clinical_Summary.pdf"]
    },
    "fda_approved_indication": {
      "met": true,
      "indication": "Moderate-to-severe Crohn's disease with fistulizing disease",
      "source_documents": ["01_Prior_Auth_Request_Form.pdf"]
    }
  },

  "overall_pa_readiness": {
    "status": "URGENT_SUBMISSION_RECOMMENDED",
    "pending_items": [
      "TB screening results (ordered 2024-10-18, expected by 2024-10-25)",
      "Hepatitis B panel results (ordered 2024-10-18, expected by 2024-10-25)"
    ],
    "all_clinical_criteria_met": true,
    "recommendation": "Submit PA immediately with pending screening results to follow. All clinical criteria are met: severe fistulizing Crohn's (CDAI 425, SES-CD 22), complete step therapy failure (5-ASA, corticosteroids, immunomodulator), fistulizing phenotype qualifies as alternative step therapy pathway per Cigna policy. Screening tests are ordered and results expected within 5-7 days — can be submitted as supplemental documentation. Delay in submission risks patient deterioration given 3 ER visits in 30 days, 14 lb weight loss, and ongoing fistula drainage.",
    "clinical_urgency_factors": [
      "Three ER visits in 30 days requiring IV hydration and pain management",
      "Unintentional weight loss of 14 lbs (8% body weight) in 6 weeks",
      "Active perianal fistula with persistent drainage confirmed by MRI",
      "Steroid-dependent at 25mg prednisone with ongoing active disease",
      "Hemoglobin 9.4 with severe iron deficiency — risk of transfusion requirement",
      "Albumin 2.6 indicating significant nutritional compromise",
      "Prescriber attests risk of bowel obstruction, abscess, or emergent surgery if biologic initiation is delayed"
    ],
    "compensating_factors_for_missing_screening": [
      "Fistulizing phenotype independently qualifies under Cigna CLINICAL_CD_FISTULAS criterion (bypasses conventional step therapy requirement)",
      "Lab severity bundle: CRP 42 + albumin 2.6 + ESR 55 — historical cohort data shows 85% approval rate for this pattern",
      "Severity overrides screening gap: historical data shows 78% approval when CRP >15 + severe classification despite missing TB screening",
      "Tests are ordered (not permanently missing) — results can be supplied within the standard PA review window",
      "Low pre-test probability for TB and HBV based on patient risk factors and vaccination history"
    ]
  }
}
